Liberty One Investment Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-47,687
| Closed | -$239K | – | 189 |
|
|
2023
Q4 | $239K | Buy |
47,687
+109
| +0.2% | +$547 | 0.03% | 118 |
|
|
2023
Q3 | $80.4K | Sell |
47,578
-3,009
| -6% | -$5.09K | 0.01% | 130 |
|
|
2023
Q2 | $141K | Buy |
50,587
+19,698
| +64% | +$54.8K | 0.02% | 130 |
|
|
2023
Q1 | $56.2K | Buy |
30,889
+810
| +3% | +$1.47K | 0.01% | 134 |
|
|
2022
Q4 | $153K | Sell |
30,079
-43
| -0.1% | -$218 | 0.02% | 122 |
|
|
2022
Q3 | $150K | Buy |
30,122
+18,042
| +149% | +$89.8K | 0.02% | 122 |
|
|
2022
Q2 | $173K | Sell |
12,080
-16,984
| -58% | -$243K | 0.03% | 126 |
|
|
2022
Q1 | $163K | Sell |
29,064
-20,400
| -41% | -$114K | 0.02% | 132 |
|
|
2021
Q4 | $301K | Buy |
49,464
+37,504
| +314% | +$228K | 0.05% | 112 |
|
|
2021
Q3 | $116K | Sell |
11,960
-120
| -1% | -$1.16K | 0.02% | 137 |
|
|
2021
Q2 | $173K | Buy |
+12,080
| New | +$173K | 0.03% | 137 |
|